David Einhorn's Greenlight Capital made several bets in energy and health care during the third quarter, according to a new securities filing.
That position was worth $65.2 million.
Greenlight also bought up shares in biotech names Gain Therapeutics and Coya Therapeutics , increasing those stakes by 7.7% and 19.2%, respectively.
The fund's largest position, homebuilding stock Green Brick Partners , was worth more than $512 million as of the end of September.
Greenlight has soared past the broader market this year, returning 12.9% in the third quarter to bring its 2023 gains to more than 27%.
Persons:
David Einhorn's, Einhorn, Russia's, Greenlight
Organizations:
Holdings, Securities, Exchange, Southwestern Energy, Consol Energy, Therapeutics, Coya Therapeutics, Green Brick Partners, Kyndryl Holdings
Locations:
Israel, Ukraine, U.S